<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T04:53:39Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/16046" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/16046</identifier><datestamp>2026-09-24T01:07:32Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Valliant, John F.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Rathmann, Stephanie</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Chemistry</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-10-07T18:56:09Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-10-07T18:56:09Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2014-11</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/16046</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/21378</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">This thesis describes the synthesis, characterization, and biological testing of iodinated probes derived from halogenated triazoles, and the effect of substituents on the clearance and tumour to non-target ratios in murine models of melanoma. Following the preparation of a small library of stannylated candidates biodistribution studies for the corresponding radioiodinated probes were performed in C57Bl/6 mice bearing B16F1tumours. Among the compounds tested an iodinated triazole containing a piperidine and phenyl moiety, 125I-7g, showed the most promising results with high tumour to liver and eye to liver ratios (27 and 81 respectively) at 24 hours. SPECT/CT imaging was consistent and showed excellent tumour visualization with a very high signal to noise ratio, which was attributed to effective clearance of the 1,4 triazole core. As the most promising candidate 125I-7g offers a platform from which to develop melanin specific radiopharmaceutical with optimal clearance and tumour to non-target ratios.&#xd;
Using the results from the SAR study, the lead constructs were the basis for preparing second generation agents using antibody recruiting, bioorthogonal targeting and dendrimer platforms. A small molecule, antibody recruiting agent was synthesized, specific to melanoma, a scaffold previously shown successful with prostate cancer. A one pot click reaction was performed between an azide functionalized with the targeting vector, and an alkyne fuctionalized with a PEG-dinitrophenyl moiety. The reaction produced an iodinated triazole in 50% yield, which was used as a non-radioactive standard. The corresponding 125I derivative was also synthesized through a one pot click&#xd;
reaction, and isolated in 36% radiochemical yield with greater than 95% radiochemical purity. Unfortunately biodistribution studies showed limited uptake in the tumour (&lt;1 %ID/g) at 24 hours.&#xd;
As an alternative to active targeting of melanoma, the BZA core was functionalized with a trans-cyclooctene (TCO) group, which is known to undergo a bioorthogonal click reaction with tetrazines in vivo. The TCO derivative was synthesized in 60% overall yield and administered to C57Bl/6 animal model prior to injection of a previously reported iodinated tetrazine. The data showed higher uptake in the tumour and the eyes, 0.7 and 6%ID/g respectively, when compared to the control group, 0.1 and 0.8 %ID/g respectively. These initial results indicate that the pretargeting approach holds significant promise in developing an effective approach to imaging and treating melanoma using medical isotopes.&#xd;
In an attempt to improve tumour uptake an aminobenzyl piperidine targeting vector, which was used to prepare compound 7g, was linked to a poly (2,2-bis(hydroxymethyl)-propanoic acid) (PMPA) generation one dendrimer through carbamate linkages. The product was isolated in 28% percent yield, and subsequently deprotected and combined with a stannylated triazole in 27% yield. The stannylated derivative was treated with Na125I and iodogen to give the radiolabelled compound in 19% RCY. Unfortunately biodistribution studies showed limited uptake in the tumour (&lt;1 %ID/g) at 24 hours. Two more functionalized dendrimers were synthesized, however due to time constraints the molecules were not evaluated in vivo.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">FUNCTIONAL GROUP INFLUENCE ON UPTAKE AND TUMOUR TO NON-TARGET RATIOS FOR IODINATED MELANOMA IMAGING AND THERAPY AGENTS</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>